Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of VRNA will rise by +0.28% over the next 2 Weeks and hit $107.21 by Monday, October 20, 2025. In that time frame, VRNA's share price is expected to range between $103.22 and $111.17.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Oct 20, 2025 | 103.04 | 107.21 | 111.22 |
| Oct 17, 2025 | 103.71 | 107.19 | 110.55 |
| Oct 16, 2025 | 104.31 | 107.19 | 110.00 |
| Oct 15, 2025 | 104.77 | 107.15 | 109.54 |
| Oct 14, 2025 | 105.19 | 107.05 | 108.98 |
| Oct 13, 2025 | 105.62 | 107.04 | 108.55 |
| Oct 10, 2025 | 106.00 | 107.01 | 108.10 |
| Oct 9, 2025 | 106.36 | 107.01 | 107.71 |
| Oct 8, 2025 | 106.65 | 106.97 | 107.34 |
| Oct 7, 2025 | 106.77 | 106.87 | 106.99 |
VRNA shares rose +0.11% in Tuesday, October 7, 2025's trading session, rising from a previous close of $106.79 to move at $106.91. The stock demonstrated notable intraday movement (see VRNA's key stats for a full breakdown), fluctuating between $106.91 and $106.91, a 0 trading range. While recent weeks have seen some volatility, VRNA has managed to secure a +0.62% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.87M shares changing hands, 193.43K more than the previous session. This amounted to $199.85M in total market activity.
Will VRNA Continue Its Upward Trend?
According to analyst ratings and projections for VRNA, Verona Pharma plc shares are anticipated to increase by +3.88%, potentially reaching $111.22 per share by October 20, 2025. Short-term technical indicators currently suggest a neutral sentiment for VRNA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 19 positive trading days within the past 30 sessions. Based on the VRNA stock forecast, now is a good time to buy VRNA stock because its current trading price is -0.28% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on VRNA covering social and institutional perspectives.
VRNA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into VRNA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 70.52% to 75.74%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 66.25%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 64.01%, points to growing bullish momentum over the long term. Insights into VRNA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Verona Pharma Short-Term Forecasts
VRNA Forecast For Next 5 Days
Our algorithm anticipates Verona Pharma (VRNA) stock could hit $106.94 by Oct 31, 2025. This represents a +0.02% rise from today's price, following a +0.28% change over the past five days.
VRNA Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Verona Pharma plc (VRNA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $106.86, which would mean a -0.05% decrease from the current price of $106.91. Projections for this period range from a high of $107.13 to a low of $106.55.
VRNA Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Verona Pharma's price over the next three months point to a drop. VRNA stock is expected to peak at $96.93 on May 06, 2026 after potentially dipping to $72.70 on Mar 09, 2026. On average, VRNA is likely to trade around $84.20 in the coming 90 days.
Verona Pharma Stock Forecast 2025
Based on our predictive models, Verona Pharma (VRNA) is expected to trade between $72.70 and $109.02 throughout 2026. This would result in an average price of $88.90, potentially offering investors a -16.85% return from current levels.
Verona Pharma plc Monthly Forecast 2025–2026
October 2025
According to our latest forecast models, Verona Pharma plc (VRNA) is positioned to show a strong performance in October 2025. The price is predicted to move between $63.03 and $79.47, settling at an average of $70.72. This could translate to a -33.85% loss.
November 2025
Based on current market signals, Verona Pharma plc is projected to trend november 2025. We forecast a trading range from $64.97 to $87.22, with a likely average price of $76.73. Investors could expect a potential return of -28.23%.
December 2025
Our predictive algorithms indicate Verona Pharma plc stock may see a shift in December 2025. The expected range spans $71.57–$89.38, with an average target of $80.61. This represents a cautious outlook and a possible loss of -24.60%.
January 2026
Analyzing established trends, Verona Pharma plc looks set to move in January 2026. Projections place the stock between $73.06 and $90.52, averaging around $81.61. This suggests a -23.66% loss from current levels.
February 2026
Market indicators suggest Verona Pharma plc could experience notable changes during February 2026. Prices could fluctuate within $72.87 to $92.86, with a midpoint forecast of $83.01. The stock might deliver a -22.36% loss.
March 2026
Forecasting for March 2026, models estimate that Verona Pharma plc may undergo key fluctuations. If trends hold, the stock might trade between $72.70 and $89.45, averaging $80.95. This signals a cautious trajectory with potential returns around -24.28%.
April 2026
According to our latest forecast models, Verona Pharma plc (VRNA) is positioned to show a strong performance in April 2026. The price is predicted to move between $75.47 and $96.57, settling at an average of $87.05. This could translate to a -18.58% loss.
May 2026
Based on current market signals, Verona Pharma plc is projected to trend may 2026. We forecast a trading range from $81.60 to $99.37, with a likely average price of $91.03. Investors could expect a potential return of -14.85%.
June 2026
Our predictive algorithms indicate Verona Pharma plc stock may see a shift in June 2026. The expected range spans $82.46–$100.89, with an average target of $91.82. This represents a cautious outlook and a possible loss of -14.11%.
July 2026
Analyzing established trends, Verona Pharma plc looks set to move in July 2026. Projections place the stock between $82.99 and $102.81, averaging around $93.14. This suggests a -12.88% loss from current levels.
August 2026
Market indicators suggest Verona Pharma plc could experience notable changes during August 2026. Prices could fluctuate within $82.78 to $100.24, with a midpoint forecast of $91.01. The stock might deliver a -14.87% loss.
September 2026
Forecasting for September 2026, models estimate that Verona Pharma plc may undergo key fluctuations. If trends hold, the stock might trade between $87.62 and $107.14, averaging $97.82. This signals a cautious trajectory with potential returns around -8.50%.
October 2026
According to our latest forecast models, Verona Pharma plc (VRNA) is positioned to show a strong performance in October 2026. The price is predicted to move between $93.99 and $109.02, settling at an average of $100.75. This could translate to a -5.76% loss.
VRNA's history of dividends and stock splits also plays a role in long-term investor confidence.